External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose
The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Risk prediction in paracetamol (acetaminophen, or APAP) poisoning treated with acetylcysteine helps guide initial patient management and disposition. The paracetamol-aminotransferase multiplication product may be a useful and less time-sensitive risk predictor. OBJECTIVE: The aim of this study was to validate this multiplication product in an independent cohort of patients with paracetamol overdose. MATERIALS AND METHODS: Using an existing toxicology dataset of poisoned patients from two large inner-city United Kingdom teaching hospitals, we retrospectively identified by electronic search all paracetamol overdoses from February 2005 to March 2013. We assessed the diagnostic accuracy of the multiplication product (serum APAP concentration × alanine transaminase [ALT] activity), especially at the pre-specified cut-off points of 1 500 mg/L × IU/L (10 000 micromol/L × IU/L) and 10 000 mg/L × IU/L (66 000 micromol/L × IU/L). The primary outcome was hepatotoxicity defined by a peak ALT > 1000 IU/L. RESULTS: Of 3823 total paracetamol overdose presentations, there were 2743 acute single, 452 delayed single (> 24 h post overdose), 426 staggered (ingestion over > 1 h), and 202 supratherapeutic ingestions. Altogether, 34 patients developed hepatotoxicity. Among the acute single-ingestion patients, a multiplication product > 10 000 mg/L × IU/L had a sensitivity of 80% (95% confidence interval [CI]: 44%, 96%) and specificity of 99.6% [99.3%, 99.8%], while a product > 1 500 mg/L × IU/L had a sensitivity of 100% [66%, 100%] and specificity of 92% [91%, 93%]. Overall, 16 patients with a multiplication product > 10 000 mg/L × IU/L developed hepatotoxicity (likelihood ratio: 250, 95% CI: 130, 480), and 4 patients with a multiplication product between 1 500 and 10 000 (likelihood ratio: 2.5, 95% CI: 1.0, 6.0). No patient with a product < 1 500 mg/L × IU/L who received acetylcysteine developed hepatotoxicity. CONCLUSIONS: Regardless of ingestion type, a product > 10 000 mg/L × IU/L was associated with a very high likelihood, and < 1 500 mg/L × IU/L with a very low likelihood, of developing hepatotoxicity in patients treated with acetylcysteine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diagnostic accuracy of this product has been confirmed, with an initial multiplication product of > 10,000 mg/L x IU/L being strongly associated with hepatotoxicity [88].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [88]
In the citing paper
“Patients with a product of <1500 mg/L x IU/L were very unlikely to develop hepatotoxicity [88].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [88]
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., & Proudfoot, A. T. (1980) · BMJ · doi:10.1136/bmj.280.6206.46-b · Cited by 626
PLASMA-PARACETAMOL HALF-LIFE AND HEPATIC NECROSIS IN PATIENTS WITH PARACETAMOL OVERDOSAGE
Prescott, L. F., Roscoe, P., Wright, N., & Brown, S. S. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91125-1 · Cited by 611
Acetylcysteine for Acetaminophen Poisoning
Heard, K. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0708278 · Cited by 467
Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Rumack, B. H., & Dart, R. C. (2012) · Clinical Toxicology · doi:10.3109/15563650.2012.746424 · Cited by 421
Acetaminophen Overdose: 662 Cases With Evaluation of Oral Acetylcysteine Treatment
Rumack, B. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030112020 · Cited by 350
A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993)
Makin, A. J., Wendon, J., & Williams, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90758-0 · Cited by 319
Research works printed but not linked: 2
- Buckley N, 2005, Clin Evid, 14, 1738
- 10.1136/bmj.2218 · doi:10.1136/bmj.2218
Cited by
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
“The diagnostic accuracy of this product has been confirmed, with an initial multiplication product of > 10,000 mg/L x IU/L being strongly associated with hepatotoxicity [88].”
BackgroundRisk prediction of hepatotoxicity in paracetamol poisoning
Wong, A., & Graudins, A. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1317349 · Cited by 88
“The high multiplication products in later presentations may be secondary to early liver injury which can be influenced by either a persistently high paracetamol concentration or a rising aminotransferase concentration [56], and can be reflected in a prolonged paracetamol elimination half-life.”
BackgroundSelf-citationGlaser, N., Feistkorn, E., Begemann, K., Aquarone, D., Ebbecke, M., Eyer, F., Liebetrau, G., Schaper, A., Seidel, C., Stedtler, U., et al. (2016) · Clinical Toxicology · doi:10.3109/15563650.2016.1165952 · Cited by 66
Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5)
Chiew, A. L., James, L. P., Isbister, G. K., Pickering, J. W., McArdle, K., Chan, B. S. H., & Buckley, N. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.030 · Cited by 53
Acetylcysteine in paracetamol poisoning: a perspective of 45 years of use
Bateman, D. N., & Dear, J. W. (2019) · Toxicology Research · doi:10.1039/c9tx00002j · Cited by 53
Metadata
- Authors
- Wong, A., Sivilotti, M. L. A., Dargan, P. I., Wood, D. M., & Greene, S. L.
- Affiliations
- Austin Hospital (AU)
- Queen's University (CA)
- King's College London (GB)
- Corresponding author
- Wong, Anselm
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2015-07-15
- Volume
- 53
- Issue
- 8
- Pages
- 807-814
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W1770761605
- Cited by
- 41
- References
- 28
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 8 · 2021: 7 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 3
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
- Keywords
- acetaminophen overdose, acetaminophen toxicity, hepatotoxicity, alanine aminotransferase, N-acetylcysteine, risk prediction, external validation, diagnostic accuracy
- MeSH terms
- Acetaminophen, Acetylcysteine, Adult, Alanine Transaminase, Antidotes, Decision Support Techniques, Clinical Enzyme Tests, Female, United Kingdom, Hospitals, Teaching, Humans, Male, Predictive Value of Tests, Retrospective Studies, Risk Factors, Time Factors, Reproducibility of Results, Biomarkers, Likelihood Functions, Databases, Factual, Treatment Outcome, Risk Assessment, Analgesics, Non-Narcotic, Chemical and Drug Induced Liver Injury, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. https://app.cochat.ai/papers/10.3109/15563650.2015.1066507
- The paper
- Wong, A., Sivilotti, M. L. A., Dargan, P. I., Wood, D. M., & Greene, S. L. (2015). External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clinical Toxicology. https://doi.org/10.3109/15563650.2015.1066507
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.